INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/14/2026
Back to search
Official data from USPTO
ARTHROSAMID
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ARTHROSAMID
ST13
US500000079230999Class
5, 10
Filing
79230999
Registration
5736094
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
07/14/2026
Trademark type
Word
Nice classes
5, 10
Filing date
03/23/2018
Registration date
04/30/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/14/2025
Last transaction
07/14/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
65
Owner location
DK
Examiner
GULIANO, ROBERT N
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Contura A/S
Representatives
Løje, Arnesen & Meedom LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical and surgical preparations for the treatment of arthritis; injectable medicated surgical gels for the alleviation of arthritis symptoms and for use in treatment of arthritis and other degenerative joint diseases; injectable gels for the treatment of arthritis; medical and surgical gels for surgical use for the alleviation of arthritis and other degenerative joint diseases; injectable gels for surgical use for the alleviation of arthritis symptoms and for use in the treatment of arthritis and other degenerative joint diseases
Class 10
Medical and surgical implants made of artificial material; injectable medical and surgical implants made of artificial material for surgical use; injectable medical and surgical implants made of artificial material for the treatment of arthritis
Publications
History of USPTO decisions and trademark events.
34 publications found
C71T
CANCELLED SECTION 71
11/14/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/06/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/26/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/09/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/04/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/22/2019
FIMP
FINAL DISPOSITION PROCESSED
08/22/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/30/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2019
GPNX
NOTIFICATION PROCESSED BY IB
03/08/2019
PUBO
PUBLISHED FOR OPPOSITION
02/12/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/23/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/23/2019
NPUB
NOTICE OF PUBLICATION
01/23/2019
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
12/14/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/07/2018
CNRT
NON-FINAL ACTION MAILED
11/05/2018
CNRT
NON-FINAL ACTION WRITTEN
11/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2018
RFNT
REFUSAL PROCESSED BY IB
08/10/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/19/2018
RFRR
REFUSAL PROCESSED BY MPU
07/19/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/07/2018
CNRT
NON-FINAL ACTION WRITTEN
07/06/2018
DOCK
ASSIGNED TO EXAMINER
07/06/2018
MAFR
APPLICATION FILING RECEIPT MAILED
05/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/30/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
04/26/2018
Continuous trademark protection
Get notified about every new filing that threatens ARTHROSAMID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.